Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al > Summary
Court Case Number 1:17-cv-00483
Filing Date Apr 28, 2017
Termination Date Dec 22, 2020
Court Delaware District Court
Status Statistical Closing
JudgesRichard G. Andrews
Plaintiff Attorneys
9BAYER SAS
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Defendant Attorneys
Aurobindo Pharma
Attorney Name: Jeffrey T. Castellano
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09539218 | Prevention and treatment of thromboembolic disorders | Jan 10, 2017 |
